Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 9/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9052184 | 0.84 | MEN1 (0.32) | MEN1ALDH1A1CYP3A4KMT2ACYP19A1 | |
| SCHEMBL9053292 | 0.84 | MEN1 (0.32) | MEN1ALDH1A1CYP3A4KMT2ACYP19A1 | |
| SCHEMBL5789683 | 0.73 | CYP19A1 (0.30) | CYP19A1 | |
| SCHEMBL25650007 | 0.71 | — | — | |
| SCHEMBL660760 | 0.67 | — | — | |
| SCHEMBL20034242 | 0.67 | — | — | |
| SCHEMBL11807732 | 0.67 | CA1 (0.32) | KMT2A | |
| SCHEMBL5818626 | 0.66 | LMNA (0.33) | LMNATSHR | |
| SCHEMBL1681830 | 0.65 | MEN1 (0.41) | MEN1ALDH1A1CYP3A4KMT2A | |
| SCHEMBL23098591 | 0.64 | CA1 (0.33) | MEN1KMT2ALMNATSHRCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151112-A1 | PYRAZOLOPYRIMIDINE DERIVATIVE AS CYCLIN-DEPENDENT KINASE 9 INHIBITOR | 주식회사 티움바이오 | 2024-07-18 | — | — | WO | disclosed |
| WO-2024067709-A1 | PYRIDINYLAMIDE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND MEDICAL USE THEREOF | 苏州阿尔脉生物科技有限公司 | 2024-04-04 | — | — | WO | disclosed |